Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Giles

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Protein Chemistry and Structural Biology|March 20, 2022
Clostridioides difficile: Current overview and future perspectivesJoanna Giles, April Roberts
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class IJoanna Giles, Jackie Shaw, Christopher Piper, et al.
Frontiers in Microbiology|October 19, 2020
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent <i>Clostridioides difficile</i> Infection in Pre-clinical ModelsApril K Roberts, Hannah C Harris, Michael Smith, et al.
Arthritis and Rheumatism|May 12, 2012
Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritisSravan K Payeli, Simon Kollnberger, Osiris Marroquin Belaunzaran, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Protein Chemistry and Structural Biology|March 20, 2022
Clostridioides difficile: Current overview and future perspectivesJoanna Giles, April Roberts
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class IJoanna Giles, Jackie Shaw, Christopher Piper, et al.
Frontiers in Microbiology|October 19, 2020
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent <i>Clostridioides difficile</i> Infection in Pre-clinical ModelsApril K Roberts, Hannah C Harris, Michael Smith, et al.
Arthritis and Rheumatism|May 12, 2012
Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritisSravan K Payeli, Simon Kollnberger, Osiris Marroquin Belaunzaran, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Pageof 1